Ophthalmic Consultants of Long Island Inject Patient With JETREA

Daniel Kiernan, MD, of Ophthalmic Consultants of Long Island injected a patient suffering from vitreo-macular adhesion with JETREA, a dilution of ocriplasmin that is the first FDA approved drug to treat VMA, according to a report by the Times Union.

Advertisement
Carrie Pallardy

This procedure was the first injection of the drug on Long Island.

JETREA, approved by the FDA in 2012, will be available at other Ophthalmic Consultants of Long Island locations.

More Articles on Ophthalmology:
Dr. Ryan Walsh Joins Medical College of Wisconsin
Miller School of Medicine, International Team Discover Seven Genes Linked to Macular Degeneration
Report Estimates Optical Imaging Market Worth $1.9B by 2018

Modeling Success: Real-World Strategies for Recurrent Pericarditis Care

Recommended OnDemand Webinar

Advertisement

Next Up in Ophthalmology

  • Montana physician practice acquired 

    Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

    By: Patsy Newitt

  • Louisiana ophthalmology practice acquired 

    Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

    By: Patsy Newitt
Advertisement

Comments are closed.